Heal
-
DATABASE (312)
-
ARTICLES (3)
The Hague-based social impact investor invests in the areas of environment, economic inclusion, health and well-being and follows the socio-economic principles of the United Nation’s Global Social Development Goals. The VC was established in 2019 and to date has invested in four companies. Its most recent investments have been in agritech sustainability monitoring platform Satelligence’s $2.3m seed round and AI-powered sustainable recruiting platform Equalture’s €1m seed round.
The Hague-based social impact investor invests in the areas of environment, economic inclusion, health and well-being and follows the socio-economic principles of the United Nation’s Global Social Development Goals. The VC was established in 2019 and to date has invested in four companies. Its most recent investments have been in agritech sustainability monitoring platform Satelligence’s $2.3m seed round and AI-powered sustainable recruiting platform Equalture’s €1m seed round.
SEEDS Capital is the investment arm of Enterprise Singapore supporting locally based startups that have innovative technologies and global market potential. Sectors of focus include advanced manufacturing & engineering, health & biomedical sciences, urban sustainability & solutions, fintech, artificial intelligence and agritech. SEEDS currently works with more than 500 deep tech startups, and over 40 incubators, accelerators and venture capital firms.
SEEDS Capital is the investment arm of Enterprise Singapore supporting locally based startups that have innovative technologies and global market potential. Sectors of focus include advanced manufacturing & engineering, health & biomedical sciences, urban sustainability & solutions, fintech, artificial intelligence and agritech. SEEDS currently works with more than 500 deep tech startups, and over 40 incubators, accelerators and venture capital firms.
Beijing Zhongguancun Development Frontier Enterprise Investment Fund
Beijing Zhongguancun Development Frontier Enterprise Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on artificial intelligence and big data, mainly investing in sectors like industrial internet, connected vehicles, biotechnology and healthcare.
Beijing Zhongguancun Development Frontier Enterprise Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on artificial intelligence and big data, mainly investing in sectors like industrial internet, connected vehicles, biotechnology and healthcare.
Founded in 2016 in Boulder, Colorado, Blackhorn specializes in startup investment in potential game-changers for industry, including construction – its top priority for investment – manufacturing, healthcare, agriculture, transportation, water and energy. It has no geographical bias and currently has 48 companies in its portfolio with two acquisitions to date. Its most recent investments include in the undisclosed $8m round of US medtech Cytovale in January 2021 and in the $20.5m December 2020 Series A round of employees compensation fintech Foresight Risk, based in Silicon Valley.
Founded in 2016 in Boulder, Colorado, Blackhorn specializes in startup investment in potential game-changers for industry, including construction – its top priority for investment – manufacturing, healthcare, agriculture, transportation, water and energy. It has no geographical bias and currently has 48 companies in its portfolio with two acquisitions to date. Its most recent investments include in the undisclosed $8m round of US medtech Cytovale in January 2021 and in the $20.5m December 2020 Series A round of employees compensation fintech Foresight Risk, based in Silicon Valley.
D Moonshots is an investment fund created by Romanian entrepreneur Sacha Dragic, founder of the Superbets online sports betting group. The Cyprus-based investor was founded in 2019 and typically invests €100,000-500,000. To date, the firm has invested in Romanian medtech Medicai’s €500,000 seed round and UK-based soft-skills VR software Bodyswaps’ £470,000 seed funding.
D Moonshots is an investment fund created by Romanian entrepreneur Sacha Dragic, founder of the Superbets online sports betting group. The Cyprus-based investor was founded in 2019 and typically invests €100,000-500,000. To date, the firm has invested in Romanian medtech Medicai’s €500,000 seed round and UK-based soft-skills VR software Bodyswaps’ £470,000 seed funding.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
Mercy Corps’ Social Venture Fund
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
Based in Seattle, Washington, Pivotal Ventures was founded by Melinda Gates in 2015 as a separate, independent organization from the Bill & Melinda Gates Foundation. The VC-arm and incubator aim to foster social innovation in the US, focusing on the social progress of women and families. It has supported diversity & inclusion, healthcare and impact startups by providing early-stage funding to enterprises with philanthropic and scalable goals. In October 2020, Pivotal launched a fund for adolescent mental health in partnership with Panorama Global. In September 2020, it also joined Techstars to create a new accelerator program to find innovative eldercare solutions for seniors and their caregivers.
Based in Seattle, Washington, Pivotal Ventures was founded by Melinda Gates in 2015 as a separate, independent organization from the Bill & Melinda Gates Foundation. The VC-arm and incubator aim to foster social innovation in the US, focusing on the social progress of women and families. It has supported diversity & inclusion, healthcare and impact startups by providing early-stage funding to enterprises with philanthropic and scalable goals. In October 2020, Pivotal launched a fund for adolescent mental health in partnership with Panorama Global. In September 2020, it also joined Techstars to create a new accelerator program to find innovative eldercare solutions for seniors and their caregivers.
Horus Capital is a private equity firm founded at the end of 2012. It currently manages over RMB 10bn in assets and is focused on healthcare, AI, media, consumer goods, new materials and energy. The company has invested in about 100 companies.
Horus Capital is a private equity firm founded at the end of 2012. It currently manages over RMB 10bn in assets and is focused on healthcare, AI, media, consumer goods, new materials and energy. The company has invested in about 100 companies.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Neurafarm: Putting an AI plant doctor in farmers' hands
This startup is riding on Indonesia’s urban farming trend with its planting kit and an AI-powered app that identifies plant diseases from photos of unhealthy leaves
HypeLabs wins bumper US$3m seed funding to democratize connectivity
HypeLab's P2P mesh networking technology enables everyone to communicate within their own networks without needing internet, in cities, remote villages and even in disaster zones
Knokcare: Telemedicine app connects you to doctors in 30 minutes
Seeking funding of over €1m, Portugal’s digital healthcare pioneer is expanding its SaaS to tap new markets in Europe, Africa and Latin America
Sorry, we couldn’t find any matches for “Heal”.
POPULAR DATABASE
